Main menu

Precision genomics for hereditary cancer with adaptive sampling

The Oxford Nanopore Hereditary Cancer Panel offers comprehensive germline variant analysis across 258 cancer predisposition genes. The panel uses adaptive sampling: a fast and flexible on-sequencer target enrichment methodology. No lengthy library preparation, baits, or primers required.

Why choose the Oxford Nanopore Hereditary Cancer Panel?

One consolidated assay for deeper genomic and epigenomic insight
Rapid, streamlined sequencing — no batching required
Flexible enrichment. Scalable sequencing. Built for every lab.
hereditary cancer panel coverage depth
Recommended device for the Hereditary Cancer Panel

PromethION 24

The PromethION 24 (P24) is a high-throughput sequencing device featuring 24 independent flow cells positions, allowing users to sequence multiple samples simultaneously or flexibly scale their experiments.

PromethION 24 Sequencing device

Flyer: Hereditary Cancer Panel — 2 pages

Hereditary Cancer Panel flyer: targeted sequencing via adaptive sampling

Accurately resolve complex structural variants (SVs), single nucleotide variants (SNVs), and insertions/deletions (indels) with the Oxford Nanopore Hereditary Cancer Panel — a comprehensive sequencing assay.

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag